RxDoctor Payments Data

Vu Truong

Family · Fountain Valley, CANPI 1831799071

Payments from drug & device makers

$3,289in general payments, 2019–2025

Across 142 payments — averaging $23.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$689
  • Lilly USA, LLC$469
  • Boehringer Ingelheim$388
  • AbbVie$333
  • Amgen$288
  • Aimmune Therapeutics, Inc.$261
  • plus $861 from 14 others

What the payments were for

  • Food & beverage$3,289100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,289 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.

See all family providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin108$85,847
Diclofenac Sodium64$80,159
VascepaIcosapent Ethyl140$69,299
FarxigaDapagliflozin Propanediol87$62,496
TradjentaLinagliptin87$57,192
JanuviaSitagliptin Phosphate64$47,553
EliquisApixaban43$39,739
ZenpepLipase/Protease/Amylase25$33,906
RestasisCyclosporine39$32,697
LinzessLinaclotide40$23,953
ProliaDenosumab13$22,109
Cyclosporine48$21,487
Icosapent Ethyl84$20,537
CreonLipase/Protease/Amylase16$17,607
OzempicSemaglutide12$16,091

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$388$143,039195 claims
AstraZenecaFarxiga, Breztri Aerosphere, Brilinta$689$87,423132 claims
AbbVieRestasis, Linzess, Creon$333$74,25795 claims
PfizerEliquis$32$39,73943 claims
Aimmune Therapeutics, Inc.Zenpep$261$33,90625 claims
AmgenProlia$288$22,10913 claims
Novo NordiskOzempic$133$16,09112 claims
BayerKerendia$15$8,55413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,634 family providers in California.

Other family in Fountain Valley

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →